# Cardiomodulatory Effects of Gender-Affirming Hormone Therapy

> **NCT07128771** · — · ENROLLING_BY_INVITATION · sponsor: **University Hospital, Akershus** · enrollment: 450 (estimated)

## Conditions studied

- Gender Incongruence
- Cardiovascular Disease (CVD) Risk Factors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07128771
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-05
- **Primary completion:** 2027-08
- **Final completion:** 2030-10
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07128771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07128771, "Cardiomodulatory Effects of Gender-Affirming Hormone Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07128771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*